ABSTRACT:
In the clinical management of arthritis, the choice of nonsteroidal anti-inflammatory drug (NSAID) remains confusing and controversial. The main objective of this review is to addresses the main arguments for the pharmacological and clinical use of COX-2 inhibitors for the clinical management of arthritis. This review concluded that, COX-2 inhibitors are effective and are associated with increased risk of GI, renal, and CV, adverse effects. Complete understanding of the patient's co-morbid conditions and concomitant medications, coupled with precise monitoring during the treatment, may help to decrease the threat of adverse effects induced by selective COX-2 inhibitors.
Cite this article:
Gayathri Devi Kumaresan, Dhanraj M.. Efficacy of Cox-2 inhibitors in the Clinical Management of TMJ Arthritis: A Review. Research J. Pharm. and Tech 2017; 10(12): 4439-4441. doi: 10.5958/0974-360X.2017.00817.4
Cite(Electronic):
Gayathri Devi Kumaresan, Dhanraj M.. Efficacy of Cox-2 inhibitors in the Clinical Management of TMJ Arthritis: A Review. Research J. Pharm. and Tech 2017; 10(12): 4439-4441. doi: 10.5958/0974-360X.2017.00817.4 Available on: https://rjptonline.org/AbstractView.aspx?PID=2017-10-12-68